Evidence-based clinical use of insulin premixtures

Table 2 Insulin premixture formulations

Manufacturer	Commercial name	Composition
Eli Lilly and Company	Humulin® 70/30	70% human insulin isophane suspension, 30% regular human insulin
	Humalog® Mix25™	25% insulin lispro, 75% insulin lispro protamine suspension
	Humalog® Mix50™	50% insulin lispro, 50% insulin lispro protamine suspension
Novo Nordisk	Novolin® 70/30^*	70% human insulin isophane suspension, 30% regular human insulin
Novo Nordisk	NovoMix® 30	70% protamine-crystallized insulin aspart and 30% insulin aspart
	NovoMix® 50^*	50% protamine-crystallized insulin aspart and 50% insulin aspart

* Not available commercially in Brazil but still available in many other countries; approved by the U.S. Food and Drug Administration and the European Medicines Evaluation Agency.

ISSN: 1758-5996